Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.44 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 2/20 | 0.44 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanyl Glutamine SCHEMBL133886 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL31140886 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL28215332 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL4274839 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL8427100 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL8813935 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL133887 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL29804717 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518502 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518470 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257330-A1 | Multipurpose Compositions for Collecting and Transporting Biological Material | LONGHORN VACCINES AND DIAGNOSTICS, LLC (US) | 2025-08-14 | — | — | US | claimed |
| EP-4568500-A1 | HYDRATION COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-06-18 | — | — | EP | claimed |
| CN-120130466-A | Cornea endothelial cell protecting liquid for reducing metabolism of cornea endothelial cells | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2025-06-13 | — | — | CN | claimed |
| CN-116064375-B | Proliferation culture medium and proliferation culture method for primary pig liver cells | 广东乾晖生物科技有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-118542316-B | Cornea endothelial cell protection liquid containing antioxidant | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2025-04-25 | — | — | CN | claimed |
| WO-2024256144-A1 | BEVERAGE POWDERS WITH DESIRABLE COLOR | UNILEVER IP HOLDINGS B.V. (NL) | 2024-12-19 | — | — | WO | claimed |
| CN-119120381-A | Method for rapidly generating CAR-T cells by using mesenchymal stem cell-derived engineering exosome-mediated mRNA | 博雅干细胞科技有限公司 | 2024-12-13 | — | — | CN | claimed |
| CN-118995608-A | Bionic material containing brain organoids and preparation method and application thereof | 浙江大学医学院附属第一医院(浙江省第一医院) | 2024-11-22 | — | — | CN | claimed |
| US-20240373840-A1 | METHODS, SYSTEMS AND COMPOSITIONS FOR RESTORATION AND PRESERVATION OF INTACT ORGANS IN A MAMMAL | YALE UNIVERSITY (US) | 2024-11-14 | — | — | US | claimed |
| CN-118805774-A | Cornea metaphase preservation solution containing high molecular dextran | 山东第一医科大学附属眼科医院(山东省眼科医院) | 2024-10-22 | — | — | CN | claimed |
| US-8445466-B2 | Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof | ENERGY BEVERAGES LLC | 2013-05-21 | — | — | US | claimed |
| WO-2012078270-A2 | EFFICIENT AND EFFECTIVE SUPPLEMENT SCREENING FOR THE DEVELOPMENT OF CHEMICALLY DEFINED MEDIA IN CELL CULTURE | ABBOTT LABORATORIES (ES) | 2012-06-14 | — | — | WO | claimed |
| EP-2377578-A1 | Stable aqueous compositions comprising amide-protected bioactive creatine species and uses thereof | Owoc, John H. (US) | 2011-10-19 | — | — | EP | claimed |
| US-20110251280-A1 | Stable Aqueous Compositions Comprising Amide-Protected Bioactive Creatine Species and Uses Thereof | ENERGY BEVERAGES LLC | 2011-10-13 | — | — | US | claimed |
| EP-2268805-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | Halozyme, Inc. (US) | 2011-01-05 | — | — | EP | claimed |
| WO-2009111066-A1 | LARGE-SCALE PRODUCTION OF SOLUBLE HYALURONIDASE | HALOZYME, INC. (US) | 2009-09-11 | — | — | WO | claimed |
| CN-101151369-A | Dipeptide crystals and process for production thereof | KYOWA HAKKO KOGYO KK (JP) | 2008-03-26 | — | — | CN | claimed |
| EP-1868430-A2 | COMPOSITION AND METHOD FOR IN VITRO PRESERVATION OF CORNEAL TISSUES | Cleo Cosmetic and Pharmaceutical Co., LLC (US) | 2007-12-26 | — | — | EP | claimed |
| WO-2006110552-A2 | COMPOSITION AND METHOD FOR IN VITRO PRESERVATION OF CORNEAL TISSUES | CLEO COSMETIC AND PHARMACEUTICAL CO., LLC (US) | 2006-10-19 | — | — | WO | claimed |
| US-5374551-A | Measurement of metabolism of alpha-methyl glucoside | BIOLOG, INC. (US) | 1994-12-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251280-A1 | Stable Aqueous Compositions Comprising Amide-Protected Bioactive Creatine Species and Uses Thereof | REN, CKMT1A; CKMT1B, GLS | NOD1 4059/4885KMT2A 2867/4885ALOX15 2361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.